PRESS-RELEASE ·Filed Mar 2, 2026
Press release: earnings
Actionable Insight • Neutral
Traders should monitor the upcoming earnings call for any material updates on financial performance, pipeline progress, or commercialization of the FDA EUA-authorized monoclonal antibody.
Final — all horizons settled through T+60d
IVVD ▼ -30.25% at T+60d
NEUTRAL call ✗ call lost -30.25% · α vs SPY -40.56% · entry $1.62 → $1.13
T+1d
+5.56%
call +5.56% · α +4.79%
$1.71
settled 7mo ago
T+5d
+12.96%
call +12.96% · α +13.44%
$1.83
settled 7mo ago
T+20d
-19.75%
call -19.75% · α -15.35%
$1.30
settled 6mo ago
T+60d
-30.25%
call -30.25% · α -40.56%
$1.13
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Invivyd announced it will host a conference call on March 5, 2026, to discuss its Q4 and full-year 2025 financial results and provide a corporate update. The press release contains no financial data or material operational updates, serving only as a notification of the upcoming earnings event.
Key Facts
- Invivyd will host a conference call on March 5, 2026, at 8:30 a.m. ET.
- The call will cover Q4 and full-year 2025 financial results and a corporate update.
- No financial figures, guidance, or operational results were disclosed in the release.
- A webcast and replay will be available via the company’s investor relations website.
Financial Impact
No financial data disclosed
Risk Factors
- Lack of disclosed financials increases uncertainty ahead of the earnings call.
- Biotech stocks like IVVD can be volatile around earnings and regulatory updates.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3247875 |
15 reports for IVVD
75% Hit rate best @ T+20▲ +35.85%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $0.8800 $0.8441 | ▼ −4.08% | ▼ −5.26% | $0.8221 (−6.58%) |
Aug 17, 2026 6w ago | 144 | $0.8680 $0.8198 | ▼ −5.55% | ▼ −4.56% | $0.8221 (−5.29%) |
Jul 6, 2026 12w ago | 8-K | $0.8340 $0.5350 | ▲ +35.85% | ▲ +35.29% | $0.8221 (+1.43%) |
Jun 16, 2026 15w ago | Press Release | $0.8918 $0.8008 | ▼ −10.20% | ▼ −10.40% | $0.8221 (−7.82%) |
Jun 11, 2026 16w ago | Institutional Cluster | $0.8125 $0.8037 | ▼ −1.08% | ▼ −2.97% | $0.8221 (+1.18%) |
Jun 9, 2026 16w ago | Press Release | $0.9900 $0.9418 | ▼ −4.87% | ▼ −6.32% | $0.8221 (−16.96%) |
Jun 1, 2026 17w ago | Press Release | $1.22 $0.8724 | ▼ −28.49% | ▼ −27.19% | $0.8221 (−32.61%) |
May 14, 2026 20w ago | 8-K | $1.16 $0.7700 | ▼ −33.62% | ▼ −32.76% | $0.8221 (−29.13%) |
May 14, 2026 20w ago | Press Release | $1.16 $0.7700 | ▼ −33.62% | ▼ −32.76% | $0.8221 (−29.13%) |
Apr 9, 2026 25w ago | 8-K | $1.78 $1.46 | ▼ −17.98% | ▼ −25.55% | $0.8221 (−53.81%) |
Showing 10 of 15
US Market Status
Market Closed — Opens Mon (64h 37m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access